| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |